Ajmera Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 12-12-2024
- Paid Up Capital ₹ 2.00 M
as on 12-12-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 12-12-2024
- Satisfied Charges ₹ 1.21 Cr
as on 12-12-2024
- Revenue 14.17%
(FY 2022)
- Profit 9.73%
(FY 2022)
- Ebitda 423.02%
(FY 2022)
- Net Worth -359.17%
(FY 2022)
- Total Assets -4.07%
(FY 2022)
About Ajmera Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹1.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amar Ajmera and Paresh Ajmera serve as directors at the Company.
- CIN/LLPIN
U24232MP1992PTC007165
- Company No.
007165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ajmera Pharmaceuticals Pvt Ltd offer?
Ajmera Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pharmaceutical Capsules, Energy Capsules, Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic Medicine, Herbal Platelet Capsule & Tablet, Ayurvedic Immunity Booster, Kadha, Ayurvedic Fever Tablet, Herbal Skin Care Cosmetics.
Who are the key members and board of directors at Ajmera Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Ajmera  | Director | 01-May-2006 | Current |
| Paresh Ajmera | Director | 01-Sep-2001 | Current |
Financial Performance of Ajmera Pharmaceuticals.
Ajmera Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 14.17% increase. The company also saw a slight improvement in profitability, with a 9.73% increase in profit. The company's net worth observed a substantial decline by a decrease of 359.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajmera Pharmaceuticals?
In 2021, Ajmera Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Jun 2013 | ₹4.50 M | Open |
Madhya Pradesh Financial Corporation Creation Date: 14 Mar 2012 | ₹2.00 M | Satisfied |
Madhya Pradesh Financial Corporation Creation Date: 22 Aug 2009 | ₹5.00 M | Satisfied |
How Many Employees Work at Ajmera Pharmaceuticals?
Ajmera Pharmaceuticals has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajmera Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajmera Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
